Assyro AI

FDA Orange Book · active-ingredient family

Ketotifen fumarate

Ketotifen fumarate is approved as 3 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

3

Brand (NDA)

5

Generics (ANDA)

2

Listed patents

0

Exclusivity periods

Brand (NDA) products · drug-eluting contact lens, solution/drops

ProductApplicantApplicationTEApproved
ACUVUE THERAVISION WITH KETOTIFENRLDJOHNSON JOHNSON VISNNDA 022388Feb 25, 2022
ALAWAYRLD×2BAUSCH AND LOMBNDA 021996Dec 01, 2006
ZADITORRLDALCON PHARMANDA 021066Oct 19, 2006

Generic (ANDA) products (5)

ProductApplicantApplicationTEApproved
ALAWAYBAUSCH AND LOMB INCANDA 208158Sep 24, 2020
KETOTIFEN FUMARATEUNICHEMANDA 204059Jun 01, 2020
ZADITORALCON PHARMS LTDANDA 077200Sep 02, 2008
KETOTIFEN FUMARATESENTISSANDA 077958Jul 26, 2007
KETOTIFEN FUMARATEAPOTEX INCANDA 077354May 09, 2006

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9474746Mar 27, 2028in 1 yr 10 mo
Product
9962376Jun 27, 2030in 4 yr 1 mo
Product

Ketotifen fumarate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.